Diabetes Drugs: Victoza and Byetta - Health Blog - WSJ
Links shared publicly online about this topic.
- 1,427total visits
Diabetes Drugs: Victoza and Byetta - Health Blog - WSJ
View full resource at blogs.wsj.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Drug, Byetta, Victoza
Most Recently Shared on January 26, 2010 at 8:19 pm By:
New Diabetes-Drug Rival Could Be a Promising Sign for Amylin http://bit.ly/bG9sbY
Diabetes Drugs Byetta, Victoza Scrutinized For Possible Cancer Link | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Diabetes Drugs Byetta, Victoza Scrutinized For Possible Cancer Link | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on September 16, 2011 at 7:31 am By:
Diabetes Drugs Byetta, Victoza Scrutinized For Possible Cancer Link: Two popular diabetes… http://t.co/lXjR4ehG
New Drug Approved :: Diabetes Self-Management
diabetesselfmanagement.com — “On january 25, the us food and drug administration (fda) approved the injectable diabetes medicine liraglutide (brand name victoza), developed by novo nordisk. victoza is the first once-daily treatment in the class of drugs known as glp-1 agonists. (exenatide [byetta] is the other member of the drug class.)” View full resource at diabetesselfmanagement.com
Most Recently Shared on January 29, 2010 at 9:10 pm By:
Diabetes Self-Mgmt Health Site
The FDA has approved a new injectable medicine for the treatment of Type 2 #diabetes. http://bit.ly/aOPHak
Cancer Warning on Novo's Victoza Is Sanofi's Chance for Revenge | BNET Pharma Blog | BNET
industry.bnet.com — “Some of the people cheering loudest at the FDA’s approval of Novo Nordisk (NVO)’s new diabetes drug, Victoza, will be Sanofi-Aventis (SNY)” View full resource at industry.bnet.com
Most Recently Shared on January 26, 2010 at 3:54 pm By:
Jim Edwards Health Communicator
Cancer Warning on Novo's Victoza Is Sanofi's Chance for Revenge: Some of the people cheering loudest at the FDA's ... http://bit.ly/4H3LXY
Advertisement
